
Home » FDA Grants Breakthrough Status on Checkpoint’s Electrostimulation Therapy System
FDA Grants Breakthrough Status on Checkpoint’s Electrostimulation Therapy System

Checkpoint Surgical has earned the FDA’s breakthrough designation for its brief electrostimulation therapy system (BEST), a device designed to treat nerve injuries.
The device is intended to be used in combination with surgical intervention following nerve injury to speed up patient recovery.
BEST uses low-level electrical currents to stimulate a patient’s peripheral nerves and encourage nerve regeneration.
Upcoming Events
-
28Sep
-
28Sep
-
11Oct
-
16Oct
-
26Oct
-
08Nov